One in 5 Americans dies in or shortly after discharge from an intensive care unit (ICU), an outcome that exposes critical care clinicians to frequent discussions that concern end-of-life care.
Summary Content
The STAR Trial (Tamoxifen and Raloxifene); FDA Actions
The treatment of acutely decompensated heart failure (ADHF) has changed dramatically in the past decade. As discussed in Part I, there is a new understanding of the pathophysiology and a significant improvement in our ability to diagnose heart failure with BNP and NT-pro BNP testing.
There are two types of noninvasive ventilation: positive pressure and negative pressure. Negative pressure ventilation is not commonly used and will be only briefly described.
Heart failure (HF) continues to cause substantial morbidity and mortality in the United States, accounting for a higher portion of Medicare costs than any other disease.
